Amplifon S.p.A Revenue 2019-2024 | AMFPF

Amplifon S.p.A annual/quarterly revenue history and growth rate from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Amplifon S.p.A revenue for the quarter ending September 30, 2024 was $0M, a 100% decline year-over-year.
  • Amplifon S.p.A revenue for the twelve months ending September 30, 2024 was $1.759B, a 4.09% decline year-over-year.
  • Amplifon S.p.A annual revenue for 2024 was $2.607B, a 6.58% increase from 2023.
  • Amplifon S.p.A annual revenue for 2023 was $2.446B, a 9.56% increase from 2022.
  • Amplifon S.p.A annual revenue for 2022 was $2.233B, a 3.13% decline from 2021.
Amplifon S.p.A Annual Revenue
(Millions of US $)
2024 $2,607
2023 $2,446
2022 $2,233
2021 $2,305
2020 $1,777
2019 $1,940
2018 $1,609
Amplifon S.p.A Quarterly Revenue
(Millions of US $)
2024-09-30
2024-03-31 $622
2023-03-31 $580
2022-03-31 $556
2021-03-31 $532
2020-03-31 $401
2019-03-31 $445
2018-12-31 $456
2018-09-30 $353
2018-06-30 $430
2018-03-31 $380
Sector Industry Market Cap Revenue
Medical Medical Services $5.378B $2.607B
Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $145.424B 27.27
CVS Health (CVS) United States $85.300B 10.60
Elevance Health (ELV) United States $78.589B 10.14
Cencora (COR) United States $57.416B 19.98
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.088B 0.00
Labcorp Holdings (LH) United States $21.920B 17.78
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.673B 0.00
Solventum (SOLV) United States $13.582B 14.38
CochLear (CHEOY) Australia $12.960B 0.00
ICON (ICLR) Ireland $12.122B 11.27
Revvity (RVTY) United States $11.941B 20.55
Viatris (VTRS) United States $10.939B 3.76
Avantor (AVTR) United States $9.458B 13.74
Medpace Holdings (MEDP) United States $9.240B 24.54
HealthEquity (HQY) United States $8.834B 38.70
Sonic Healthcare (SKHHY) Australia $8.518B 0.00
Charles River Laboratories (CRL) United States $7.717B 15.12
Caris Life Sciences,�Inc (CAI) United States $6.752B 0.00
Bausch + Lomb (BLCO) Canada $4.910B 28.92
BrightSpring Health Services (BTSG) United States $3.889B 35.68
Sotera Health (SHC) United States $3.334B 18.94
Surgery Partners (SGRY) United States $2.839B 36.92
Alignment Healthcare (ALHC) United States $2.685B 0.00
Concentras Parent (CON) United States $2.635B 15.23
GeneDx Holdings (WGS) United States $2.614B 100.67
Organon (OGN) United States $2.589B 2.75
PACS (PACS) United States $2.003B 0.00
Ardent Health (ARDT) United States $1.915B 8.16
Progyny (PGNY) United States $1.840B 40.49
Premier (PINC) United States $1.812B 13.76
GoodRx Holdings (GDRX) United States $1.682B 33.64
Teladoc Health (TDOC) United States $1.454B 0.00
Establishment Labs Holdings (ESTA) $1.259B 0.00
Pediatrix Medical (MD) United States $1.184B 9.01
CareDx (CDNA) United States $1.071B 16.73
Agilon Health (AGL) United States $1.006B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.919B 0.00
AMN Healthcare Services Inc (AMN) United States $0.839B 7.86
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Nutex Health (NUTX) United States $0.658B 9.96
Embecta (EMBC) United States $0.603B 4.06
InnovAge Holding (INNV) United States $0.602B 0.00
LifeMD (LFMD) United States $0.568B 0.00
Sonida Senior Living (SNDA) United States $0.481B 0.00
Omada Health (OMDA) $0.480B 0.00
Auna S.A (AUNA) Luxembourg $0.469B 10.55
SBC Medicals (SBC) United States $0.463B 0.00
Enhabit (EHAB) United States $0.387B 31.88
So-Young (SY) China $0.330B 0.00
Performant Healthcare (PHLT) United States $0.328B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.305B 0.00
Beauty Health (SKIN) United States $0.287B 0.00
Oncology Institute (TOI) United States $0.225B 0.00
DocGo (DCGO) United States $0.161B 26.33
Pheton Holdings (PTHL) China $0.126B 0.00
Sera Prognostics (SERA) United States $0.094B 0.00
KindlyMD (NAKA) United States $0.077B 0.00
Ascend Wellness Holdings (AAWH) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
ModivCare (MODV) United States $0.047B 0.00
Biodesix (BDSX) United States $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Basel Medical Group (BMGL) Singapore $0.032B 0.00
OSR Holdings (OSRH) United States $0.026B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00